News

Read our News and Publications

30 de November, 2022
Our three co-founders are among the Women Innovation EU Prize finalists
2022
28 de September, 2022
Best-in-class canceR dIaGnostic cHip for patient sTratification
Project acronym: BRIGHT Project name: Best-in-class canceR dIaGnostic cHip for patient sTratification. Project co-funded by the: European Innovation Council Project number: 190138134 Project Description:Through advanced microengineering […]
5 de April, 2022
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study
2022
22 de January, 2022
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
2023
3 de September, 2021
HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device
2023
24 de May, 2021
RUBYnanomed is part of the 2021 IGNITE Cohort
MassMEDIC, the Massachusetts Medical Device Industry Council, announced today the 2021 IGNITE Cohort, and RUBYnanomed was one of the awarded medtech startups. Press release: follow the link
18 de August, 2020
RUBYnanomed highlighted as a startup to watch by cLAB Ventures
cLAB Ventures launched a mentorship programme to accelerate the business development of startups innovating in the field of oncology, and RUBYnanomed was highlighted as a startup […]
24 de July, 2020
RUBYnanomed gets support from La Caixa Foundation
RUBYnanomed was awarded the prestigious Caixa Impulse Consolidate funds to help the fight against cancer. The project intends to build an automated system for non-invasive diagnosis […]
5 de November, 2019
RUBYnanomed awarded as an emerging technology in health by the Royal Society of Chemistry
The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early stage companies and academic entrepreneurs who want to commercialise their technologies to […]
29 de May, 2019
The Significance of Circulating Tumour Cells in the Clinic
2023
21 de October, 2018
Next Big Idea (SIC Notícias)
Sara Abalde mostra-nos um dispositivo transparente que tem lá dentro um circuito que quase parece uma pauta de música. É um objeto pequenino, talvez com menos […]
25 de September, 2018
Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
2020
30 de June, 2018
Grand prize and Crowd Favourite prize in Berlin at the Advanced Materials Competition (AdMaCom2018)
The Advanced Materials Competition (AdMaCom2018) is a fast-paced 2 week Accelerator Program for Startups in Advanced Materials organised by the global innovation network for advanced materials […]
14 de August, 2017
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases
2023
14 de July, 2017
Novo dispositivo permite detectar precocemente metástases em doentes com cancro (PT)
Um dispositivo descartável que permite detectar precocemente metástases em doentes com cancro está a ser desenvolvido por investigadoras de Braga com o apoio do Instituto de […]
23 de May, 2013
RUBYnanomed @ Start Up the Science podcast
RUBYnanomed was invited to participate in the INAM – Innovation Network for Advanced Materials podcast – “Start Up the Science”. In this episode, CEO Lorena Diéguez […]